Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05407675 |
|---|---|
| Brief Title: | A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors |
| First Submitted : | June 2, 2022 |
| First Submitted that Met QC Criteria : | June 2, 2022 |
| First Posted : | June 7, 2022 |
| Last Update Submitted that Met QC Criteria : | March 12, 2024 |
| Last Update Posted : | March 15, 2024 |